BDX 財務： Becton Dickinson and Co AI 分析

首頁

股票

BDX

財務狀況

BDX 財務

Becton Dickinson and Co

$155.32

0.52%

$0.8

收盤價：Apr 06, 16:00:00 GMT-4

$155.9

0.37%

$0.58

盤後：Apr 06, 20:00:00 GMT-4

概觀預測收益股利財務狀況

關鍵數據

前收市價

$154.51

開盤價

$153.79

當日範圍

$152.98 - $155.93

52週區間

$127.53 - $187.35

交易量

1.8M

平均成交量

2.3M

股息收益率

2.51%

每股盈餘 (TTM)

6.12

市值

$44.3B

什麼是 BDX？

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.

功能特性

資源

市場

收入

資產負債表

現金流量

年度

每季

BDX 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	09/30/2025	09/30/2024	09/30/2023	09/30/2022	09/30/2021
營收	21,924	21,840	20,178	19,372	18,870	19,131
營收年增率 (YoY)	6%	8%	4%	3%	-1%	19%
營收成本	11,747	11,817	11,015	10,549	10,267	10,444
毛利	10,177	10,023	9,163	8,823	8,603	8,687
銷售、一般及管理費用	5,352	5,278	4,857	4,719	4,709	4,719
研發	1,227	1,235	1,190	1,237	1,256	1,279
營業費用	6,593	6,514	6,257	6,000	5,983	6,360
其他非營業收入 (費用)	-102	-57	-11	-66	-17	-7
稅前淨利	1,969	1,881	2,005	1,662	1,783	1,692
所得稅費用	212	203	300	132	148	88
淨利	1,757	1,678	1,705	1,424	1,689	2,002
淨利成長	1%	-2%	20%	-16%	-16%	161%
稀釋後流通股數	285.84	288.5	291	288.39	287	292
股數年變動 (YoY)	-2%	-1%	1%	0%	-2%	4%
每股盈餘 (稀釋)	6.14	5.81	5.85	4.93	5.88	6.85
每股盈餘成長率	2%	-1%	19%	-16%	-14%	153%
自由現金流	2,631	2,670	3,073	2,115	1,661	3,452
每股自由現金流	--	--	--	--	--	--
毛利率	46.41%	45.89%	45.41%	45.54%	45.59%	45.4%
營業利益率	16.34%	16.06%	14.4%	14.57%	13.88%	12.16%
淨利率	8.01%	7.68%	8.44%	7.35%	8.95%	10.46%
自由現金流利潤率	12%	12.22%	15.22%	10.91%	8.8%	18.04%
EBITDA	6,053	5,971	5,192	5,111	4,849	4,557
EBITDA 利潤率	27.6%	27.33%	25.73%	26.38%	25.69%	23.81%
EBITDA 中的折舊與攤銷	2,469	2,462	2,286	2,288	2,229	2,230
EBIT	3,584	3,509	2,906	2,823	2,620	2,327
EBIT 利潤率	16.34%	16.06%	14.4%	14.57%	13.88%	12.16%
有效稅率	10.76%	10.79%	14.96%	7.94%	8.3%	5.2%

Follow-Up Questions

Quels sont les états financiers clés de Becton Dickinson and Co ?



Selon le dernier état financier (Form-10K), Becton Dickinson and Co a un total d'actifs de $55,325, un bénéfice net 利潤 de $1,678

Quels sont les ratios financiers clés pour BDX ?



Le ratio de liquidité de Becton Dickinson and Co est 1.84, la marge nette est 7.68, les ventes par action sont de $75.69.

Comment les revenus de Becton Dickinson and Co sont-ils répartis par segment ou géographie ?



Becton Dickinson and Co 最大收入來源為 Medication Delivery Solutions，在最近的收益報告中收入為 4,575,000,000。就地區而言，United States 是 Becton Dickinson and Co 的主要市場，收入為 12,790,000,000。

Becton Dickinson and Co est-elle rentable ?



是的, selon les derniers états financiers, Becton Dickinson and Co a un bénéfice net 利潤 de $1,678

Becton Dickinson and Co a-t-elle des passifs ?



是的, Becton Dickinson and Co a un passif de 29,935

Combien d'actions en circulation Becton Dickinson and Co a-t-elle ?



Becton Dickinson and Co a un total d'actions en circulation de 285.4

Becton Dickinson and Co (BDX) 財務

BDX 股價走勢圖